covid-19-vaccine-in-india Pfizer oral pill for Covid-19 gets US FDA approval Company to increase production of Paxlovid from 80 million to 120 million courses of treatment in 2022; plans to launch worldwide with voluntary licenses to other manufacturers By P B Jayakumar
covid-19-vaccine-in-india Common global rules must for new Covid drug trials: Adar Poonawalla Poonawalla says the biggest learning from the pandemic has been the realisation that one should not make forward looking predictions, as things have been changing fast with Covid-19 By Joe Mathew
covid-19-vaccine-in-india Covid 19 syringe shortage threat averted as Haryana eases pollution curbs Factories allowed to run eight hours a day, five days a week and use diesel genset only in case of power outages. By Joe Mathew
covid-19-vaccine-in-india Serum's new Covid vaccine Covovax gets WHO nod WHO chief scientist Soumya Swaminathan congratulated Serum Institute, Adar Poonawalla and Novavax for offering one more highly effective and safe vaccine. By Joe Mathew
covid-19-vaccine-in-india Children will not get Covid vaccine anytime soon: Here’s why The rollout of the vaccine for kids is to be delayed by weeks or months as government wants adequate supplies, distribution infrastructure and fool-proof evidence before inoculating children. By P B Jayakumar
covid-19-vaccine-in-india Next target for Covid vaccine: 200 crore; How soon? 100 crore shots and rising. By Joe Mathew
multimedia Mix and match vaccines, says Kiran Mazumdar-Shaw In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive. By V. Keshavdev
enterprise Adar Poonawalla’s tough choices India’s vaccine giant faces the huge social responsibility of supply into the domestic market and a contractual demand for export of vaccines to foreign countries. By Anto T. Joseph
enterprise The Ellas of Bharat Biotech: The gift of the jab Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company. By Anshul Dhamija
covid-19-vaccine-in-india Will India’s new liberalised vaccine market work? In a big move, India has opened up Covid-19 vaccinations for all adults. However, the country is beset by severe vaccine shortage and other challenges. Will increasing the demand base work? By Anto T. Joseph
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
Will NDA’s landslide victory in Maharashtra election boost market sentiment? Here’s what analysts say
